<DOC>
	<DOCNO>NCT02373124</DOCNO>
	<brief_summary>This study evaluate feasibility treatment paradigm involve naturalistic cocaine use opportunity context psychotherapy aim utilizing opportunity therapeutically .</brief_summary>
	<brief_title>Glutamatergic Modulation Motivation Enhancement : A Pilot Feasibility Trial</brief_title>
	<detailed_description />
	<criteria>Inclusion Criterion Method Ascertainment 1 . Active cocaine dependence least 8 day use least 4 binge large amount ( &gt; $ 200/occasion ) past 30 day , display least one positive utox screen SCID , Psychiatric Interview , selfreport , utox 2 . Physically healthy Laboratory test ( urinalysis , blood chemistry , 12lead ECG normal limit ) , physical examination , selfreported medical history 3 . No adverse reaction study medication Subjects ask previous exposure ketamine midazolam 4 . 2155 year age Selfreported age , verification legal identification 5 . Capacity consent comply study procedure , include sufficient proficiency English A short write test study procedure , SCID , psychiatric interview 6 . Seeking treatment Psychiatric Interview , selfreport Exclusion Criterion Method Ascertainment 1 . Meets DSM IV criterion current major depression , bipolar disorder , schizophrenia , psychotic illness , include substance induce psychosis , current substanceinduced mood disorder HAMD score &gt; 12 . Psychiatric Interview , SCID , HAMD 2 . Physiological dependence another substance , alcohol , opioids , benzodiazepine , exclude caffeine , nicotine , cannabis SCID , Psychiatric Interview 3 . Delirium , Dementia , Amnesia , Cognitive Disorders , Dissociative disorder SCID , Psychiatric Interview 4 . Current suicide risk history suicide attempt within past year SCID , Psychiatric Interview 5 . Pregnant interested become pregnant study period Blood urine pregnancy test , selfreport 6 . Any following cardiac condition : clinically significant leave ventricular hypertrophy , angina , clinically significant arrhythmia , mitral valve prolapse Laboratory test ( 12lead ECG normal limit ) , physical examination , selfreported medical history 7 . Unstable physical disorder might make participation hazardous endstage AIDS , hypertension ( &gt; 140/90 ) , WBC &lt; 3.5 , active hepatitis liver disease elevate transaminase level ( &lt; 23 X upper limit normal consider acceptable PT/PTT normal ) , renal failure ( creat &gt; 2 , BUN &gt; 40 ) , untreated diabetes Physiological test ( urinalysis , blood chemistry , 12lead ECG ) , physical examination , selfreported medical history 8 . Previous history ketamine midazolam misuse abuse , history adverse reaction/experience prior exposure cocaine , ketamine midazolam Physical examination , selfreported medical history 9 . Recent history significant violence ( past 2 year ) SCID , Psychiatric Interview 10 . Abnormal pseudocholinesterase level Blood test 11 . First degree relative psychotic disorder ( bipolar disorder , schizophrenia , schizoaffective disorder , psychosis NOS ) SCID , Psychiatric Interview 12 . BMI &gt; 35 , history document obstructive sleep apnea Physical examination , selfreported medical history 13 . On psychotropic medication whose effect could disrupt participation study Psychiatric interview , selfreported medical history 14 . Patients comply study procedure initial hospitalization phase Study Performance</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>